SLC5A5 was reported to be downregulated in papillary and follicular thyroid cancer [43, 44] and dysregulated in patients with neurotransmitter, endocrine and immune abnormalities [45]. The gene discussed is SLC5A5; the disease is thyroid gland follicular carcinoma.